169 related articles for article (PubMed ID: 12620078)
1. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC
J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
Elmore SW; Coghlan MJ; Anderson DD; Pratt JK; Green BE; Wang AX; Stashko MA; Lin CW; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Lane BC
J Med Chem; 2001 Dec; 44(25):4481-91. PubMed ID: 11728194
[TBL] [Abstract][Full Text] [Related]
3. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
[TBL] [Abstract][Full Text] [Related]
4. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
[TBL] [Abstract][Full Text] [Related]
5. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
Hudson AR; Roach SL; Higuchi RI; Phillips DP; Bissonnette RP; Lamph WW; Yen J; Li Y; Adams ME; Valdez LJ; Vassar A; Cuervo C; Kallel EA; Gharbaoui CJ; Mais DE; Miner JN; Marschke KB; Rungta D; Negro-Vilar A; Zhi L
J Med Chem; 2007 Sep; 50(19):4699-709. PubMed ID: 17705362
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
Shah N; Scanlan TS
Bioorg Med Chem Lett; 2004 Oct; 14(20):5199-203. PubMed ID: 15380227
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of non-steroidal ligands for the glucocorticoid receptor: selective quinoline derivatives with prednisolone-equivalent functional activity.
Coghlan MJ; Kym PR; Elmore SW; Wang AX; Luly JR; Wilcox D; Stashko M; Lin CW; Miner J; Tyree C; Nakane M; Jacobson P; Lane BC
J Med Chem; 2001 Aug; 44(18):2879-85. PubMed ID: 11520196
[TBL] [Abstract][Full Text] [Related]
9. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK
J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents.
Giri RS; Thaker HM; Giordano T; Williams J; Rogers D; Vasu KK; Sudarsanam V
Bioorg Med Chem; 2010 Apr; 18(7):2796-808. PubMed ID: 20335039
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
[TBL] [Abstract][Full Text] [Related]
12. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
[TBL] [Abstract][Full Text] [Related]
13. trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers.
Lin CW; Nakane M; Stashko M; Falls D; Kuk J; Miller L; Huang R; Tyree C; Miner JN; Rosen J; Kym PR; Coghlan MJ; Carter G; Lane BC
Mol Pharmacol; 2002 Aug; 62(2):297-303. PubMed ID: 12130681
[TBL] [Abstract][Full Text] [Related]
14. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
Zhi L; Tegley CM; Pio B; Edwards JP; Motamedi M; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
J Med Chem; 2003 Sep; 46(19):4104-12. PubMed ID: 12954062
[TBL] [Abstract][Full Text] [Related]
15. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
[TBL] [Abstract][Full Text] [Related]
16. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
17. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK
J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361
[TBL] [Abstract][Full Text] [Related]
18. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
19. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
